China Police Detain 22 From Four Drug Makers For Tainted Drug Capsules
This article was originally published in PharmAsia News
Local Chinese police have detained 22 people from four drug companies allegedly involved in a scandal involving a banned substance in medicine capsules that can cause cancer as well as kidney and liver damage.
You may also be interested in...
With the India business on the road to recovery and the US growth outlook muted, Torrent hopes to keep the boat steady in fiscal 2021. It also expects an order in Q3 in a patent infringement case pertaining to AstraZeneca’s Farxiga, where it and multiple Indian firms are seeking to launch generic versions.
Two leading, independent bodies of French scientists, doctors and pharmacists are calling for OTC drugs containing pseudoephedrine to be reverse-switched to prescription-only status over safety fears.
COVID-19 has shifted consumer health behaviour towards prevention and general wellbeing. However, finding out what consumers actually want and need is still the essence of good OTC innovation, according to Stada Arzneimittel's new vice president of consumer healthcare product development Steve Makin.